SCHEMBL8806348

SCHEMBL8806348

COc1ccc(C(=O)Cc2cccc(S(N)(=O)=O)c2)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.47
LMNA P02545 2/20 0.47
MAPK1 P28482 1/20 0.47
RAB9A P51151 1/20 0.47
PTGS1 P23219 4/20 0.46
PTGS2 P35354 4/20 0.46
ACHE P22303 1/20 0.46
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA9 Q16790 3/20 0.45
CA12 O43570 2/20 0.45
NPC1 O15118 1/20 0.44
ROCK2 O75116 1/20 0.44
ROCK1 Q13464 1/20 0.44
GAA P10253 1/20 0.44
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
CA7 P43166 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170001 0.87 PTGS2 (0.53) HTTLMNAMAPK1RAB9APTGS1
SCHEMBL1515704 0.81 HTT (0.62) HTTLMNAMAPK1RAB9AACHE
SCHEMBL3940426 0.81 HTT (0.61) HTTLMNAMAPK1RAB9AACHE
SCHEMBL6948148 0.78 PTGS2 (0.52) HTTLMNAMAPK1RAB9APTGS2
SCHEMBL6171405 0.78 KMT2A (0.50) HTTLMNAMAPK1RAB9APTGS1
SCHEMBL29236666 0.75 HTT (0.56) HTTLMNAMAPK1RAB9AACHE
SCHEMBL1347457 0.75 HTT (0.68) HTTLMNAMAPK1RAB9AACHE
SCHEMBL30969396 0.75 HTT (0.56) HTTLMNAMAPK1RAB9AACHE
SCHEMBL2121926 0.73 PTGS2 (0.68) PTGS1PTGS2CA1CA2CA9
SCHEMBL7217060 0.72 PTGS1 (0.52) HTTLMNAPTGS1PTGS2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO disclosed